Company Filing History:
Years Active: 2001-2011
Title: **James G Lazar: Innovator in HPV Assessment and DNA-Binding Protein Detection**
Introduction
James G Lazar, based in Bethesda, MD, is a distinguished inventor known for his significant contributions to the field of medical diagnostics and molecular biology. With a total of 12 patents to his name, Lazar's work focuses primarily on innovative methods for assessing human papilloma virus (HPV) infections and the detection of DNA-binding proteins. His inventions are paving the way for advancements in early disease detection and characterization.
Latest Patents
Two of Lazar's latest patents highlight his innovative prowess in the realm of medical technology. The first patent, titled "Assessment of Human Papilloma Virus-Related Disease," provides groundbreaking methods for assessing HPV infection. Through the use of gene expression levels, this invention enables the evaluation of the progression of HPV infections from benign to malignant growth. Additionally, the patent includes kits designed for the practical application of these methods.
The second patent, "Methods of Detecting a Plurality of Sequence Specific DNA Binding Proteins with Oligonucleotide Detection Duplexes," outlines compositions and methods that facilitate the detection and measurement of multiple DNA-binding proteins simultaneously. This invention allows for the generation of profiles of DNA binding activity by proteins, particularly transcription factors. By enabling the detection of multiple protein-DNA binding events within a single sample, Lazar's invention supports high-throughput screening and analysis.
Career Highlights
Lazar's professional journey includes pivotal roles in notable companies, such as Digene Corporation and Marligen Biosciences, Inc. His tenure at these organizations showcases his commitment to advancing biotechnological innovations and improving diagnostic techniques. Through his work, he has devoted his expertise to addressing pressing health challenges.
Collaborations
Throughout his career, Lazar has collaborated with esteemed colleagues, including Attila T Lorincz and Abel De La Rosa. These partnerships underscore the collaborative spirit often essential to breakthroughs in scientific research, further enhancing the impact of Lazar's inventions in the medical field.
Conclusion
James G Lazar stands out as a leading inventor in the domain of health diagnostics, leveraging his innovative insights to enhance the understanding and detection of HPV-related diseases and DNA-binding proteins. His notable patents serve as a testament to the vital role of invention and collaboration in advancing medical technology. Lazar's work not only contributes to the scientific community but also holds the potential for significant societal benefits in disease prevention and treatment.